1. [Effect of components and some protocols of anti-ulcer therapy on content and activity of monooxigenase system enzymes of the stomach mucosa in experimental stomach ulcer].
- Author
-
Iakubov AV and Pattakhova MKh
- Subjects
- Animals, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Anti-Ulcer Agents administration & dosage, Anti-Ulcer Agents therapeutic use, Antifungal Agents administration & dosage, Antifungal Agents therapeutic use, Cytoprotection drug effects, Cytoprotection physiology, Disease Models, Animal, Drug Therapy, Combination, Gastric Mucosa enzymology, Gastric Mucosa pathology, Male, Rats, Stomach Ulcer enzymology, Stomach Ulcer pathology, Anti-Bacterial Agents adverse effects, Anti-Ulcer Agents adverse effects, Antifungal Agents adverse effects, Gastric Mucosa drug effects, Mixed Function Oxygenases antagonists & inhibitors, Stomach Ulcer drug therapy
- Abstract
The influence of components and some schemata of antiulcerous therapy on content and activity of monooxigenase system's enzymes in mucous membrane of stomach are studied on the model of experimental stomach ulcer in rats. It is established, that among components of antiulcerous therapy such as omeprazole, clarithromycin and metronidazole inhibit content and activity of MOS enzymes. Tinidazol, amoxicillin and azithromycin do not affect the function of MOS. Rifampicin and pantoprazole induce enzyme system of monooxigenase. In triple therapy with omeprazole, clarithromycin and metronidazole the inhibit effect of preparations to system of MOS is exponentiated and it leads to suppression of mucous cytoprotaction of gastro duodenal zone. Triple therapy of ulcerous disease with pantoprazole, rifampicin and azithromycin is effective planning to stimulate defense mechanisms of the organism.
- Published
- 2009